Tomographic coronary angiography by EBCT and MDCT

Applicability and potential of monitored reconstruction in computed tomography

Monitored tomographic reconstruction (MTR) is a potentially powerful tool for dose and time reduction in computed tomography scanning. We are the first to study the issue of practical implementation of MTR protocols in current-generation real-life instruments. We propose an empirical quantitative model for calculating acquisition and reconstruction times. It is demonstrated that projection acquisition order has a significant impact on the time and dose of tomographic experiments. The new alternative acquisition most suitable for MTR protocols is proposed. To estimate the restrictions and scope of applicability for MTR four typical commercial setups are studied within a proposed model. We construct an experimental stand for achieving a real-time reconstruction, together with validation of the proposed acquisition time model. We demonstrate that real-time reconstruction may be implemented without slowing down an acquisition process. An optimization of reconstruction from partial data is proposed, which allowed the production of 385 and 440 reconstructions for standard and proposed acquisition orders correspondingly during a single acquisition of 512 projections. The results of the study demonstrate that with proposed optimizations MTR can be effectively utilized for practical applications using the current generation of existing setups in industrial and nano tomography fields.

Role of multimodality imaging in ischemic and non-ischemic cardiomyopathy

Chronic heart failure (CHF) is a major and growing problem in the western hemisphere, affecting about 5 million patients in the United States. In daily practice patients with left ventricular systolic dysfunction (LVSD) and significant angiographic coronary artery disease (CAD) are felt to have an ischemic cardiomyopathy (ICMP) and those without CAD or mild-moderate CAD out of proportion to the extent of LVSD are felt to have a non-ischemic cardiomyopathy (NICMP). Although invasive coronary angiography is the gold standard for the diagnosis of CAD, recent advances in non-invasive imaging have created multiple options for evaluating ICMP and NICMP. This review details the role of cardiac imaging in the diagnosis of ICMP and NICMP and outlines an algorithm of use of non-invasive tests in asymtomatic LVSD and symptomatic heart failure.

Nonacute coronary syndrome anginal chest pain

Anginal chest pain is one of the most common complaints in the outpatient setting. While much of the focus has been on identifying obstructive atherosclerotic coronary artery disease (CAD) as the cause of anginal chest pain, it is clear that microvascular coronary dysfunction (MCD) can also cause anginal chest pain as a manifestation of ischemic heart disease, and carries an increased cardiovascular risk. Epicardial coronary vasospasm, aortic stenosis, left ventricular hypertrophy, congenital coronary anomalies, mitral valve prolapse, and abnormal cardiac nociception can also present as angina of cardiac origin. For nonacute coronary syndrome (ACS) stable chest pain, exercise treadmill testing (ETT) remains the primary tool for diagnosis of ischemia and cardiac risk stratification; however, in certain subsets of patients, such as women, ETT has a lower sensitivity and specificity for identifying obstructive CAD. When combined with an imaging modality, such as nuclear perfusion or echocardiography testing, the sensitivity and specificity of stress testing for detection of obstructive CAD improves significantly. Advancements in stress cardiac magnetic resonance imaging enables detection of perfusion abnormalities in a specific coronary artery territory, as well as subendocardial ischemia associated with MCD. Coronary computed tomography angiography enables visual assessment of obstructive CAD, albeit with a higher radiation dose. Invasive coronary angiography remains the gold standard for diagnosis and treatment of obstructive lesions that cause medically refractory stable angina. Furthermore, in patients with normal coronary angiograms, the addition of coronary reactivity testing can help diagnose endothelial-dependent and -independent microvascular dysfunction. Lifestyle modification and pharmacologic intervention remains the cornerstone of therapy to reduce morbidity and mortality in patients with stable angina. This review focuses on the pathophysiology, diagnosis, and treatment of stable, non-ACS anginal chest pain.

Coronary calcium score from multislice computed tomography correlates with QT dispersion and left ventricular wall thickness

Coronary calcium score is a marker of coronary atherosclerosis and is an important factor of cardiac events. Ventricular hypertrophy and QT dispersion increase the risk of cardiac events. The purpose of the study was to investigate whether coronary calcium score may be related to the changes of QT, QT dispersion, heart chamber size, and wall thickness. The coronary calcium score was studied in 97 patients through multislice computed tomography (MSCT). There were 32 patients with high calcium score (> or =200), 29 patients with low calcium score (1-199), and 36 patients with zero calcium score. The gender, age, incidence of hypertension, diabetics, smoking, and dyslipidemia were similar among the three groups. The QT dispersion, QTc dispersion, and R-wave amplitude in the high calcium score group were larger than those in the other two groups. There were similar P-wave duration. QRS duration, and PR interval among the three groups. The left ventricular anterior-posterior diameter and left ventricular wall thickness in the high coronary calcium score group were larger than those in the other two groups. Coronary calcium score had strong correlations with QT dispersion and left ventricular wall thickness. These findings may contribute further evidence regarding the increased risk of cardiac events in those patients with high coronary calcium score.

Multidetector computed tomography for the diagnosis of coronary artery disease: a systematic review

PURPOSE

The study's purpose was to determine the sensitivity and specificity of contrast-enhanced multidetector computed tomography (CT) for the detection of coronary artery disease.

SUBJECTS AND METHODS

A search of the literature in all languages was performed incorporating both electronic and manual components. Manual reference checks of recent reviews and all original investigations supplemented the electronic searches.

RESULTS

Average sensitivity for patient-based detection of significant (>50% or > or =50%) stenosis was 61 of 64 (95%) with 4-slice CT, 276 of 292 (95%) with 16-slice CT, and 47 of 47 (100%) with 64-slice CT. Average specificity was 84% for 4-slice CT, 84% for 16-slice CT, and 100% for 64-slice CT. The sensitivity for a significant stenosis in evaluable segments was 307 of 372 (83%) with 4-slice CT, 1023 of 1160 (88%) with 16-slice CT, and 165 of 176 (94%) with 64-slice CT. Average specificity was 93% or greater with all multidetector CT. Seventy-eight percent of segments were evaluable with 4-slice CT, 91% with 16-slice CT, and 100% with 64-slice CT. Stenoses in proximal and mid-segments were shown with a higher sensitivity than distal segments. Left main stenosis was identified with high sensitivity with all multidetector CT, but sensitivity in other vessels increased with an increasing number of detectors.

CONCLUSION

Multidetector CT has the potential to be used as a screening test in appropriate patients. Contrast-enhanced 16-slice CT seems to be reasonably sensitive and specific for the detection of significant coronary artery disease but has shortcomings. Preliminary data with 64-slice CT suggest that it is more sensitive and specific.

Visualization of coronary artery anomalies by contrast-enhanced multi-detector row spiral computed tomography

BACKGROUND

We investigated the potential of 16-slice multi-detector row spiral CT (MDCT) with retrospective ECG-gating for evaluation of coronary artery anomalies.

METHODS

A total of 35 patients (23 men, 12 women, 19-81 years) in whom anomalous coronary arteries had been detected by invasive coronary angiography underwent MDCT (Sensation 16, Siemens, Germany). During one breathhold, a contrast-enhanced (90 ml, 5 ml/s) volume data set of the heart was acquired (16x0.75mm collimation, gantry rotation 375 ms). Images were reconstructed with a slice thickness of 1.0 mm in 0.5-mm intervals using retrospective ECG-gated reconstruction. The 35 data sets and 80 data sets of patients with angiographically normal coronary anatomy were analysed in random order concerning the origin and course of the coronary arteries. The results were compared to invasive coronary angiography.

RESULTS

All patients with coronary artery anomalies and all controls with normal coronary anatomy were identified by MDCT. In addition, the origins and course concerning their anatomical relationship to adjacent cardiac structures were visualized in all patients, including right-sided origin of the left main (n=10), left anterior descending coronary artery (n=4) or left circumflex coronary artery (n=10); left-sided origin of the right coronary artery (n=6); four coronary fistula to the pulmonary artery (two from the left anterior descending, one from the right coronary artery, one from the left main), and one fistula from the circumflex coronary artery to the left atrium

CONCLUSIONS

The study demonstrates that MDCT is a reliable noninvasive technique to identify and define anomalous coronary arteries and their course.

Quantification of Calcification in Atherosclerotic Lesions

Calcification can be deposited throughout the vasculature in several forms of calcium phosphate, including calcium hydroxyapatite (CHA). Calcium accumulation in arteries by mineralization and calcium loss from bone by osteoporosis often coexist, and vascular calcification may share common mechanisms with bone remodeling. Deposition of calcification in valves and arteries diminishes the valvular or arterial wall elasticity, a major cause of aneurysm and stenosis. Obstruction of arteries by calcification and other components can lead to heart attack and stroke. Mineralization in the femoral arteries can cause intermittent claudication in the legs, causing decreased mobility. Accurate measurement of calcification is essential for identifying other factors associated with this process and ultimately for elucidating the mechanism(s) of calcification. A wide range of methods for visualizing and measuring calcification for diagnosis and treatment in vivo and for studying the calcification process ex vivo are available. This review provides a critical comparison of older established methods and newer evolving technologies for quantifying calcification.

Magnetic resonance imaging in myocardial ischemia

PURPOSE OF REVIEW

MRI is a novel strategy to assess myocardial ischemia. It provides information on myocardial perfusion, viability, and potentially the extent of coronary artery disease. This technology may replace many of the current noninvasive and, perhaps, invasive techniques in the diagnosis and management of patients with coronary artery disease. This review aims to cover the major advances in cardiac MRI related to both diagnosis and therapy of myocardial ischemia.

RECENT FINDINGS

Although improved image acquisition techniques have made it possible to obtain excellent image quality in most patients, powerful processing software has permitted the quantification of accurate and reproducible functional information regarding perfusion, wall motion, and viability. Stem cell delivery and gene therapy to the myocardium using cardiac MRI has been shown to be feasible. The use of 3-T systems for cardiac imaging and the imaging of atherosclerosis with MRI are currently being studied.

SUMMARY

MRI is a highly accurate method of characterizing both reversible and irreversible myocardial injury and of obtaining information on myocardial viability. It has the ability to prognostic patients by evaluating ejection fraction and contractility. Robust and uncomplicated methodologies for coronary MR angiography are almost on the horizon. Quantification of several parameters used to diagnose, prognosticate, and follow patients with ischemic heart disease should be much easier in the future. It may, with the recent advances in imaging such as 3-T systems, provide major noninvasive diagnostic capability. Cardiac MRI, with its improved imaging, and its ability to treat and monitor various forms of invasive and noninvasive therapy, may attain its potential as a "one-stop shop" in the near future.

[Cardio-pulmonary vascular system. Three-dimensional quantitative evaluation by microcomputed tomography]

In recent years microcomputed tomography (microCT) has become more and more important in basic research. Now commercial microCT scanners are available. Thus, it is very likely that this new, accurate and promising method for three-dimensional and non-destructive quantitative evaluation of intact tissues including vessels will be applied more frequently. The review provides a survey of the basic technology of microCT and its current use for high resolution three-dimensional morphometric and functional analysis within the cardio-pulmonary vascular system.